Univ of North Carolina School of Medicine / Div Hemat / Onco — Chapel Hill, North Carolina

Univ of North Carolina School of Medicine / Div Hemat / Onco is a clinical research site located in Chapel Hill, North Carolina, United States 275997035.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Univ of North Carolina School of Medicine / Div Hemat / Onco has participated in 1 clinical trials.

Therapeutic areas: HIV Infections, Hemophilia A.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chapel Hill

Browse all research sites in North Carolina · View every site in Chapel Hill

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Univ of North Carolina School of Medicine / Div Hemat / Onco?

Univ of North Carolina School of Medicine / Div Hemat / Onco has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Univ of North Carolina School of Medicine / Div Hemat / Onco conducted?

Univ of North Carolina School of Medicine / Div Hemat / Onco has 1 clinical trials on record. Their work covers HIV Infections, Hemophilia A.

Is Univ of North Carolina School of Medicine / Div Hemat / Onco accredited by Crixeo Clinical Trials?

Univ of North Carolina School of Medicine / Div Hemat / Onco has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Univ of North Carolina School of Medicine / Div Hemat / Onco?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.